1. Home
  2. LNN vs NBTX Comparison

LNN vs NBTX Comparison

Compare LNN & NBTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lindsay Corporation

LNN

Lindsay Corporation

HOLD

Current Price

$109.75

Market Cap

1.2B

Sector

Industrials

ML Signal

HOLD

Logo Nanobiotix S.A.

NBTX

Nanobiotix S.A.

HOLD

Current Price

$33.56

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LNN
NBTX
Founded
1954
2003
Country
United States
France
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.0B
IPO Year
1995
2018

Fundamental Metrics

Financial Performance
Metric
LNN
NBTX
Price
$109.75
$33.56
Analyst Decision
Hold
Strong Buy
Analyst Count
1
1
Target Price
$113.00
$36.00
AVG Volume (30 Days)
164.1K
41.7K
Earning Date
04-02-2026
03-31-2026
Dividend Yield
1.34%
N/A
EPS Growth
12.81
N/A
EPS
2.70
N/A
Revenue
$676,368,000.00
N/A
Revenue This Year
N/A
$58.17
Revenue Next Year
$4.74
N/A
P/E Ratio
$40.90
N/A
Revenue Growth
11.41
N/A
52 Week Low
$97.27
$3.27
52 Week High
$149.56
$41.89

Technical Indicators

Market Signals
Indicator
LNN
NBTX
Relative Strength Index (RSI) 45.49 54.42
Support Level $107.45 $29.30
Resistance Level $119.95 $34.66
Average True Range (ATR) 3.12 1.57
MACD 0.83 0.07
Stochastic Oscillator 55.23 76.19

Price Performance

Historical Comparison
LNN
NBTX

About LNN Lindsay Corporation

Lindsay Corp provides proprietary water management and road infrastructure products and services. It manufactures and distributes agricultural irrigation equipment through two segments: Irrigation and Infrastructure. The Irrigation segment makes center pivot, lateral move, and hose reel irrigation systems and parts. The Infrastructure segment produces barriers, crash cushions, road marking and safety equipment, and railroad signals. The majority of revenue is from the Irrigation segment. The company operates in the United States and international markets, with the majority of revenue coming from the United States.

About NBTX Nanobiotix S.A.

Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.

Share on Social Networks: